These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33510207)

  • 1. Body surface area capping may not improve cytotoxic drugs tolerance.
    Bouleftour W; Viard A; Mery B; Chaux R; Magne N; Simoens X; Rivoirard R; Forges F
    Sci Rep; 2021 Jan; 11(1):2431. PubMed ID: 33510207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
    Schwartz J; Toste B; Dizon DS
    Gynecol Oncol; 2009 Jul; 114(1):53-6. PubMed ID: 19359030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients.
    Hansen J; Stephan JM; Freesmeier M; Bender D; Button A; Goodheart MJ
    Gynecol Oncol; 2015 Jul; 138(1):154-8. PubMed ID: 25958318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.
    Furlanetto J; Eiermann W; Marmé F; Reimer T; Reinisch M; Schmatloch S; Stickeler E; Thomssen C; Untch M; Denkert C; von Minckwitz G; Lederer B; Nekljudova V; Weber K; Loibl S; Möbus V
    Ann Oncol; 2016 Nov; 27(11):2053-2059. PubMed ID: 27502721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.
    Cespedes Feliciano EM; Lee VS; Prado CM; Meyerhardt JA; Alexeeff S; Kroenke CH; Xiao J; Castillo AL; Caan BJ
    Cancer; 2017 Dec; 123(24):4868-4877. PubMed ID: 28881381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
    Gurney H
    J Clin Oncol; 1996 Sep; 14(9):2590-611. PubMed ID: 8823340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and dose individualization in cancer chemotherapy: the role of body surface area and body mass index.
    Portugal RD
    Med Hypotheses; 2005; 65(4):748-51. PubMed ID: 15979816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
    Raman R; Mott SL; Schroeder MC; Phadke S; El Masri J; Thomas A
    Clin Breast Cancer; 2016 Dec; 16(6):480-486. PubMed ID: 27431461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal prescription method for cancer chemotherapy.
    Vriesendorp HM
    Exp Hematol; 1985; 13 Suppl 16():57-63. PubMed ID: 3857184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body surface area estimation in children using weight alone: application in paediatric oncology.
    Sharkey I; Boddy AV; Wallace H; Mycroft J; Hollis R; Picton S;
    Br J Cancer; 2001 Jul; 85(1):23-8. PubMed ID: 11437397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are medical oncologists biased in their treatment of the large woman with breast cancer?
    Madarnas Y; Sawka CA; Franssen E; Bjarnason GA
    Breast Cancer Res Treat; 2001 Mar; 66(2):123-33. PubMed ID: 11437098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing of chemotherapy in obese and cachectic patients: results of a national survey.
    Anglada-Martínez H; Riu-Viladoms G; do Pazo-Oubiña F; Molas-Ferrer G; Mangues-Bafalluy I; Codina-Jané C; Creus-Baró N
    Int J Clin Pharm; 2014 Jun; 36(3):589-95. PubMed ID: 24771403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
    Stocker G; Hacker UT; Fiteni F; John Mahachie J; Roth AD; Van Cutsem E; Peeters M; Lordick F; Mauer M
    Eur J Cancer; 2018 Aug; 99():49-57. PubMed ID: 29906734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan.
    Kouno T; Katsumata N; Mukai H; Ando M; Watanabe T
    Jpn J Clin Oncol; 2003 Jun; 33(6):309-13. PubMed ID: 12913086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from body surface area-based to fixed dosing for the investigational proteasome inhibitor ixazomib: a population pharmacokinetic analysis.
    Gupta N; Zhao Y; Hui AM; Esseltine DL; Venkatakrishnan K
    Br J Clin Pharmacol; 2015 May; 79(5):789-800. PubMed ID: 25377318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).
    Hunter RJ; Navo MA; Thaker PH; Bodurka DC; Wolf JK; Smith JA
    Cancer Treat Rev; 2009 Feb; 35(1):69-78. PubMed ID: 18922643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Body Surface Area Formulas for the Calculation of the Chemotherapy Dosage].
    Hatahira H; Iguchi K; Sasaoka S; Motooka Y; Hasegawa S; Naganuma M; Fukuda A; Ohmori T; Yoshida T; Mogushi K; Nakamura M
    Gan To Kagaku Ryoho; 2017 Nov; 44(11):1011-1015. PubMed ID: 29138378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer.
    Lote H; Sharp A; Redana S; Papadimitraki E; Capelan M; Ring A
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):597-603. PubMed ID: 26936608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.
    Imai H; Kuwako T; Kaira K; Masuda T; Miura Y; Seki K; Sakurai R; Utsugi M; Shimizu K; Sunaga N; Tomizawa Y; Ishihara S; Ishizuka T; Mogi A; Hisada T; Minato K; Takise A; Saito R; Yamada M
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):497-505. PubMed ID: 28168310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.
    Cahu X; Carré M; Recher C; Pigneux A; Hunault-Berger M; Vey N; Chevallier P; Delaunay J; Gyan E; Lioure B; Bonmati C; Himberlin C; Hicheri Y; Guillerm G; Didier B; Larosa F; Ojeda-Uribe M; Bernard M; Bene MC; Ifrah N; Cahn JY
    Eur J Haematol; 2017 May; 98(5):443-449. PubMed ID: 28122150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.